Photodynamic therapy outcomes in a case of macular choroidal neovascularization secondary to Candida endophthalmitis

European Journal of Ophthalmology

Volumn 17, Issue 1, 2007, Pages 124-127

  Tedeschi, Massimiliano ^a   Varano, M ^a   Schiano Lomoriello, D ^a   Scassa, C ^a   Parisi, V ^a  

^a IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Candida albicans; Choroidal neovascularization; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; FLUCONAZOLE; PREDNISONE; ANTIFUNGAL AGENT; GLUCOCORTICOID; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA ENDOPHTHALMITIS; CASE REPORT; DISEASE COURSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; METAMORPHOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RELAPSE; RETINA DETACHMENT; SUBRETINAL NEOVASCULARIZATION; VISION; VISUAL ACUITY; CANDIDIASIS; DRUG COMBINATION; ENDOPHTHALMITIS; FUNGEMIA; PHOTOCHEMOTHERAPY;

ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; FEMALE; FLUCONAZOLE; FLUORESCEIN ANGIOGRAPHY; FUNGEMIA; GLUCOCORTICOIDS; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PREDNISONE; RETINAL DETACHMENT; VISUAL ACUITY;

EID: 34047254697     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700118     Document Type: Article

References (11)

1. Donahue SP, Greven CM, Zuravleff JJ, et al. Intraocular candidiasis in patients with candidemia. Clinical implication derived from a prospective multicenter study. Ophthalmology 1994; 101: 1302-9.
2. Hamza H S, Lowenstein A, Haller J A. Retiniti ed endoftalmiti fungine. In O'Brien T R ed. Oftalmologia Clinica del Nord America, (Italian edition) 1999; vol. 11:3 . Philadelphia: W.B. Saunders Company, 1999; 105-26. (Italian Edition).
3. Chen SJ, Chung YM, Liu JH. Endogenous candida endophthlmitisendophthalmitis after induced abortion. Am J Ophthalmol 1998; 125: 873-5.
4. Tsai CC, Chen SJ, Chung YM, Yu KW, Hsu WM. Postpartum endogenous candida endophthalmitis. J Forms Med Assoc 2002; 101: 432-6.
5. Shah GK, Fischer D, Fineman MS, Sharma S, Maguire J. Subretinal neovascularization secondary to Candida endophthalmitis: long term follow-up after macular surgery. Retina 1999; 19: 81-2.
6. Jampol LM, Sung J, Walker JD, et al. Choroidal neovascularization secondary to Candida albicans chorioretinitis. Am J Ophthalmol 1996; 121: 643-9.
7. Varano M, Parisi V, Tedeschi M, et al. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation. Invest Ophthalmol Vis Sci 2005; 46: 1453-62.
8. Schmidt-Erfurth U, Schlötzer-Schrehard U. Histopathological changes following photodynamic therapy in human eyes. Arch. Ophthalmol 2002; 120: 835-44.
9. Morschhauser J.. The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 2002, 18; 1587: 240-8.
10. Schreiber W, Olbrisch A, Vorwerk CK, Konig W, Behrens-Baumann W. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci 2003; 44: 2634-43.
11. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina 2005; 25: 685-90.